Business ❯ Finance ❯ Companies
Moderna Novo Nordisk Grifols FDA Approvals Tariffs Wockhardt Bayer Vertex Pharmaceuticals Sartorius Rubicon Research IPO Alnylam Pharmaceuticals Cipla Corona Remedies Lupin Ltd.
The new specialty positions the women’s health business for a projected $1 billion in 2026.
